Follow‐up of the melanoma patient
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25324
Abstract: Follow‐up of the melanoma patient involves many different methods of surveillance. Specific guidelines for modalities and frequency are flexible and largely open to physician preference. Patient education and self‐examination are generally viewed as crucial and… read more here.
Keywords: oncology; melanoma patient; follow melanoma;
An insight into the molecular genetics of a uveal melanoma patient cohort
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-018-2705-6
Abstract: Background/aimsUveal melanoma (UM) is a highly aggressive malignancy and presents a clinically significant unmet need in cancer therapeutics. The aim of this study was to identify previously unreported mutations in UM among an Irish cohort… read more here.
Keywords: patient cohort; genetics; cohort; cancer ... See more keywords
Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center
Sign Up to like & getrecommendations! Published in 2019 at "Melanoma Research"
DOI: 10.1097/cmr.0000000000000572
Abstract: Supplemental Digital Content is available in the text. read more here.
Keywords: therapy melanoma; melanoma patient; patient provider; melanoma ... See more keywords
Melanoma in a patient with DNMT3A overgrowth syndrome.
Sign Up to like & getrecommendations! Published in 2023 at "Cold Spring Harbor molecular case studies"
DOI: 10.1101/mcs.a006267
Abstract: Alterations in epigenetic regulators are increasingly recognized as early events in tumorigenesis; thus, patients with acquired or inherited variants in epigenetic regulators may be at increased risk for developing multiple types of cancer. DNMT3A overgrowth… read more here.
Keywords: dnmt3a overgrowth; melanoma patient; dnmt3a; overgrowth syndrome ... See more keywords
COVID‐19 in a melanoma patient under treatment with checkpoint‐inhibition
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.16661
Abstract: Abstract SARS‐CoV‐2 poses new challenges in all aspects of healthcare. Patients with preexisting cardio‐vascular conditions are at higher risk of developing severe symptoms and worse outcome. Data also suggest that cancer patients are particularly vulnerable,… read more here.
Keywords: treatment checkpoint; treatment; checkpoint inhibition; patient treatment ... See more keywords
Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade: A Case Report
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.592609
Abstract: Monoclonal antibodies blocking PD-1 and CTLA-4 immunological checkpoints lead to durable tumor responses in a considerable number of advanced melanoma patients. Besides their anti-neoplastic efficacy, these immune checkpoint inhibitors cause a wide range of immune-related… read more here.
Keywords: report; melanoma patient; durable complete; complete response ... See more keywords